Canaloplasty is a highly effective surgical technique for the treatment of open-angle glaucoma. Minimally invasive, it uses breakthrough microcatheter technology to restore the function of the eye’s natural outflow system without the need for a filtering bleb – offering an unprecedented level of efficacy and safety in the surgical treatment of glaucoma. As an added benefit, Canaloplasty can be used in conjunction with existing drug based glaucoma treatments, after laser or other types of incisional surgery and does not preclude or affect the outcome of future surgery.

During the procedure, the iTRACK™ 250 microcatheter is inserted into Schlemm’s canal under a scleral flap. The iTRACK™ 250 delivers viscoelastic to enlarge the canal and to dilate the collector channels. It also delivers a suture, which acts like a stent to stretch the trabecular meshwork and hold open the canal.

What causes glaucoma?
In a healthy eye, aqueous humor (fluid) is produced to nourish and clean the eye at the same rate at which it is drained in order to maintain a constant and normal intraocular pressure (IOP). A loss of drainage function leads to a high IOP, which can result in glaucoma. If left untreated, glaucoma can result in irreversible vision loss.

Is there a cure for glaucoma?
To date there is no cure for glaucoma. Glaucoma treatments are designed to slow, or halt, the progression of the disease. Your surgeon will determine what level of IOP is required in order to preserve your vision.

What are the effects of glaucoma?
Many people with glaucoma cannot drive a car safely, see their grandchildren on the soccer field, and view… Click here for answers on canaloplasty and glaucoma.

View

Less invasive than traditional glaucoma surgeries, clinical studies have shown that Canaloplasty can significantly and durably reduce IOP without the risks and discomfort associated with trabeculectomy. It can therefore be offered earlier in the disease process. Unlike conventional glaucoma surgery, Canaloplasty does not produce a filtering bleb and can therefore be performed on patients who wear contact lenses. Patients who have undergone canaloplasty can continue normal day-to-day activities directly following treatment and require minimal post-operative follow-up.

• 200-micron working-length diameter for minimally invasive procedures
• Catheter support wire to maintain better control during catheterization
• Optical fiber to illuminate the distal tip
• 250-micron bulbous atraumatic tip designed to minimize potential for tissue damage
• Lumen

View accessories